Table 1. Experimental protocol.
0 wk | 2 wk | 4 wk | 5 wk | 6 wk | 7 wk | 8 wk | 9 wk | 11 wk | 13 wk | 15 wk | |
---|---|---|---|---|---|---|---|---|---|---|---|
Group 1 (n=4) | DC | CBCT | CBCT | ||||||||
CBCT | HA | ||||||||||
Group 2 (n=4) | STZ | DC | CBCT | CBCT | |||||||
CBCT | HA | ||||||||||
Group 3 (n=4) | STZ | DC | CBCT | CBCT | |||||||
CBCT | HA | ||||||||||
Group 4 (n=5) | STZ | DC | CBCT | CBCT | |||||||
CBCT | HA | ||||||||||
Group 5 (n=1) | STZ | DC | CBCT | CBCT | |||||||
CBCT | HA |
DC: defect creation, CBCT: cone-beam computed tomography, HA: histological analysis, STZ: streptozotocin